← Back to Library GLP-1 & Metabolic

Tirzepatide (Mounjaro)

Overview

Dual GIP/GLP-1 agonist. Newer medication with strong weight loss data. Educational only.

Evidence

SURMOUNT trials show superior weight loss vs semaglutide in some studies.

Risks & Considerations

Similar GI profile. Prescription only. Consult a qualified healthcare professional.

Approximate Costs

Private prescription approximately £200–400/month.

Ask VAIA AI about Tirzepatide (Mounjaro) →

⚕ Educational information only. VAIA does not provide medical advice, diagnosis or treatment. Always speak to a qualified healthcare professional before making health decisions.